The ArdA antirestriction protein of the IncB plasmid R16 selectively inhibited the restriction activity of EcoKI, leaving significant levels of modification activity under conditions in which restriction was almost completely prevented. The results are consistent with the hypothesis that ArdA functions in bacterial conjugation to allow an unmodified plasmid to evade restriction in the recipient bacterium and yet acquire cognate modification.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC150139 | PMC |
| http://dx.doi.org/10.1128/JB.185.6.2022-2025.2003 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Platinum(IV)-Gold(I) Agents with Promising Anticancer Activity: Selected Studies in 2D and 3D Triple-Negative Breast Cancer Models.
Chemistry
October 2023
Department of Chemistry and Brooklyn College Cancer Center, Brooklyn College, The City University of New York, Brooklyn, NY, 11210, USA.
New heterometallic binuclear and trinuclear platinum(IV)-gold(I) compounds of the type [Pt(L) Cl (OH){(OOC-4-C H -PPh )AuCl} ] (L=NH , n=2; x=1, 2; L=diaminocyclohexane, DACH, n=1; x=2) are described. These compounds are cytotoxic and selective against a small panel of renal, bladder, ovarian, and breast cancer cell lines. We selected a trinuclear PtAu compound containing the Pt core based on oxaliplatin, to further investigate its cell-death pathway, cell and organelle uptake and anticancer effects against the triple-negative breast cancer (TNBC) MDA-MB-231 cell line.
View Article and Find Full Text PDFEmergence of ST11-K47 and ST11-K64 hypervirulent carbapenem-resistant in bacterial liver abscesses from China: a molecular, biological, and epidemiological study.
Emerg Microbes Infect
March 2020
Department of Clinical Laboratory, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
Multidrug-resistant bacteria, especially those with high virulence, are an emerging problem in clinical settings. We conducted a multicentre epidemiological and comparative genomic analysis on the evolution, virulence and antimicrobial resistance of carbapenem-resistant in patients with bacterial liver abscesses from 2012 to 2016. A total of 477 bacterial isolates were collected.
View Article and Find Full Text PDFB/O plasmid R16 from 1956 carries an In1-like class 1 integron embedded in a complex region containing parts of the Acinetobacter baumannii AbaR resistance island.
Plasmid
September 2019
School of Life and Environmental Sciences, The University of Sydney, NSW, Australia.
The IncB/O multiresistance plasmid R16, recovered in 1956 and used in experimental studies of B/O plasmid features, was sequenced. The resistance genes are all within a class 1 integron closely related to In1 containing the cassette array oxa2-aadA1-oxa2-orfD and the sul1 gene in the 3'-conserved segment (3'-CS), with Tn10, containing tetA(B), inserted just inside the 3'-CS. The integron is part of a 25,144 bp region inserted in the plasmid backbone, bounded on only one side by a truncated Tn6018 and flanked by a 4 bp duplication.
View Article and Find Full Text PDFAntirestriction activities of KlcA (RP4) and ArdB (R64) proteins.
FEMS Microbiol Lett
December 2018
Bacterial Genetics Laboratory, State Research Institute of Genetics and Selection of Industrial Microorganisms, 1-st Dorozhniy pr., 1, 117545 Moscow, Russia.
Antirestriction proteins of the ArdB group (ArdB, KlcA) specifically inhibit restriction (endonuclease) activity of restriction-modification (RM) type I systems. Antirestriction activity of KlcA and ArdB, encoded in transmissible plasmids RP4 (IncPα) and R64 (IncI1), respectively, has been determined. We show that the protein KlcA (RP4), an amino acid sequence identical to that of the protein KlcA (RK2), inhibits the activity of EcoKI when the klcA gene is located on the plasmid under the control of strong promoter.
View Article and Find Full Text PDFRandomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1.
PLoS One
November 2018
Centre for Amyloidosis and Acute Phase Proteins, University College London, London, United Kingdom.
Background: The failure of DNA vaccination in humans, in contrast to its efficacy in some species, is unexplained. Observational and interventional experimental evidence suggests that DNA immunogenicity may be prevented by binding of human serum amyloid P component (SAP). SAP is the single normal DNA binding protein in human plasma.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!